本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Dare Bioscience

0.7060
+0.00090.13%
盤後0.7050-0.0010-0.14%19:42 EDT
成交量:9.37萬
成交額:6.68萬
市值:1,388.64萬
市盈率:-0.91
高:0.7233
開:0.7170
低:0.7050
收:0.7051
52周最高:3.78
52周最低:0.6900
股本:1,966.91萬
流通股本:1,732.62萬
量比:0.34
換手率:0.54%
股息:- -
股息率:- -
每股收益(TTM):-0.7779
每股收益(LYR):-1.1986
淨資產收益率:-2543.13%
總資產收益率:-39.29%
市淨率:-24.76
市盈率(LYR):-0.59

資料載入中...

2021/03/30

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/30

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/08

重要事件披露

8-K - Current report
2021/02/16

重要事件披露

8-K - Current report
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/01

重要事件披露

8-K - Current report
2021/01/11

重要事件披露

8-K - Current report
2021/01/06

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/05

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/01/04

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/04

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/23

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/12/22

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/12/09

重要事件披露

8-K - Current report
2020/12/07

重要事件披露

8-K - Current report
2020/11/18

重要事件披露

8-K - Current report
2020/11/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]